Publication

Date Item Type Full Text Status

Public

Using machine learning (ML) and explainable artificial intelligence (AI) to accurately predict immune-checkpoint inhibitor (ICI) response in small cell (SCLC) and non-small cell (NSCLC) lung cancer patients. (2025) L. Sharma, V. Balaji, A. Katumba, E. Mohan, I. Mporas, D. Alrifai, J. Chow, T. Sevitt, K. Nathan, R. Shah, J.S.C. Waters and S. Adeleke